KSE - Delayed Quote KRW

Aprogen Medicines Inc. (007460.KS)

646.00
-9.00
(-1.37%)
As of 1:31:07 PM GMT+9. Market Open.
Loading Chart for 007460.KS
  • Previous Close 655.00
  • Open 653.00
  • Bid 646.00 x --
  • Ask 649.00 x --
  • Day's Range 646.00 - 664.00
  • 52 Week Range 646.00 - 1,794.00
  • Volume 989,838
  • Avg. Volume 1,739,744
  • Market Cap (intraday) 171.896B
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 27, 2007
  • 1y Target Est --

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers. The company was formerly known as Aprogen KIC Inc. and changed its name to Aprogen Medicines Inc. April 2021. Aprogen Medicines Inc. was founded in 1971 and is based in Seongnam-si, South Korea.

www.aprogen.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 007460.KS

View More

Performance Overview: 007460.KS

Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

007460.KS
16.75%
KOSPI Composite Index (^KS11)
8.54%

1-Year Return

007460.KS
50.57%
KOSPI Composite Index (^KS11)
5.02%

3-Year Return

007460.KS
85.59%
KOSPI Composite Index (^KS11)
1.32%

5-Year Return

007460.KS
93.29%
KOSPI Composite Index (^KS11)
30.90%

Compare To: 007460.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 007460.KS

View More

Valuation Measures

Annual
As of 5/19/2025
  • Market Cap

    174.29B

  • Enterprise Value

    244.33B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.26

  • Price/Book (mrq)

    1.17

  • Enterprise Value/Revenue

    1.76

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -38.69%

  • Return on Assets (ttm)

    -9.37%

  • Return on Equity (ttm)

    -23.40%

  • Revenue (ttm)

    150.11B

  • Net Income Avi to Common (ttm)

    -58.08B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    43.66B

  • Total Debt/Equity (mrq)

    25.84%

  • Levered Free Cash Flow (ttm)

    -43.85B

Research Analysis: 007460.KS

View More

Company Insights: 007460.KS

Research Reports: 007460.KS

View More

People Also Watch